BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:7th Annual Pharma Regulatory 2024\n\n&nbsp\;&nbsp\;&nbsp\;&nbs
 p\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;
 &nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;21st March
  2024\, Hotel Kohinoor Continental Hotel\, Mumbai\, India\n\n&nbsp\;\n\nT
 he 7th Annual Pharma Regulatory Summit 2024 congregates foremost global p
 harmaceutical industry professionals and regulators to share their insigh
 ts on technologies\, approaches\, and solutions that will drive innovatio
 n and quality for the medicines delivered to patients worldwide. This int
 eractional setting with expert-led regulatory and industry presentations\
 , and forums will ensure pharmaceutical industry professionals are expedi
 ent to develop and apply ingenious solutions in today’s global regulatory
  environment.\n\nPlease contact me for Sponsor / Delegate at E-mail - kav
 itha@virtueinsight.co.in or M: +91 9361957193\n\nSPONSORSHIP:\n\nWe have 
 more sponsorship opportunities available for both the events\, which give
 s you an opportunity to exhibit/booth/speak and create brand awareness. P
 lease email your interest and queries to kavitha@virtueinsight.co.in\n\nD
 ELEGATE REGISTRATION:\n\n\nSuper Early Bird Discount Price&nbsp\;(Valid t
 ill 20th January 2024) –&nbsp\;INR 12\,000 + GST (18%) per delegate\nEarl
 y Bird Discount Price&nbsp\;(21st January 2024 – 03rd March 2024) –&nbsp\
 ;INR 12\,000 + GST (18%) per delegate\nStandard Price (Valid from 04th Ma
 rch 2024)&nbsp\; - INR 17\,000 + GST (18%) per delegate\n\nKEY SPEAKERS:\
 n\n\nMAYUR PARMAR\,&nbsp\;Drugs Inspector (Deputy Collector\, Gujarat Gov
 ernment)\,&nbsp\;FDA\nAMIT PANDEY\,&nbsp\;Executive Vice President &amp\;
  General Counsel\,&nbsp\;GSK\nPRABIR KUMAR PAL\,&nbsp\;Senior Vice Presid
 ent - Quality &amp\; Compliance\,&nbsp\;Alkem Laboratories\nMUKESH KUMAR\
 ,&nbsp\;Senior VP &amp\; Head\, Clinical R&amp\;D\,&nbsp\;Cipla\nPRATIK S
 HAH\,&nbsp\;Vice President - Medical Affairs\,&nbsp\;Bharat Serums and Va
 ccines\nRASHMI HEDGE\,&nbsp\;Executive Vice President – Medical\,&nbsp\;G
 SK\nGEETA SHANBHAG\,&nbsp\;VP - Pharmacovigilance &amp\; Medico-Regulator
 y Affairs\,&nbsp\;Ipca Laboratories\nRAHUL GUPTA\,&nbsp\;Vice President\,
  Regulatory Affairs\,&nbsp\;USV\nBIJENDER MISHRA\,&nbsp\;Chief Informatio
 n Security Officer (CISO)\,&nbsp\;Alkem Laboratories\nYASHMIN SHENOY\,&nb
 sp\;Senior Director - Regulatory Affairs\,&nbsp\;Sanofi\nMILIND ANTANI\, 
 Leader\, Pharma and Healthcare\, Nishith Desai Associates \nKEDAR SUVARNA
 PATHAKI\,&nbsp\;Director - Regulatory Affairs\,&nbsp\;Johnson &amp\; John
 son\nDEVEN BABRE\,&nbsp\;Former Director Analytics &amp\; Benchmarking\,&
 nbsp\;GSK\nHARSHAD KOTHAWADE\,&nbsp\;Director\, Head of Regulatory Manage
 ment &amp\; Trade Compliance India\, South East Asia\, ANZ\,&nbsp\;Merck 
 Group\nVAIBHAV SALVI\,&nbsp\;Director &amp\; Head – Clinical Study Unit\,
  India and South East Asia\,&nbsp\;Sanofi\nPRIYA CHATTERJEE\,&nbsp\;Head 
 Regulatory Affairs - South Asia\,&nbsp\;Bayer\nDILIP PAWAR\,&nbsp\;Global
  Head - Medical Affairs and Pharmacovigilance\,&nbsp\;Unichem Laboratorie
 s\nPOOJA THAKUR\,&nbsp\;Associate Director\, Regulatory Intelligence &amp
 \; Reporting\,&nbsp\;Advanz Pharma\nMARTINA GOMES\,&nbsp\;Head\, Reg Affa
 irs – CH\,&nbsp\;Bayer\nAKSHAYA S. ODAK\,&nbsp\;Head Regulatory Affairs (
 Biotech)\, Lupin\nSADANAND KULKARNI\,&nbsp\;Head- Medical\, Regulatory\, 
 Vigilance &amp\; Quality South Asia\,&nbsp\;Fresenius Kabi\nMAYUR MAYBHAT
 E\,&nbsp\;Head Medical Affairs\,&nbsp\;Alkem Laboratories\nGIRISH SANE\,&
 nbsp\;Section Head PV\,&nbsp\;Macleods Pharmaceuticals\nJEGAN ISRAEL\,&nb
 sp\;Head of Quality &amp\; Compliance (General Manager)\,&nbsp\;Zydus Gro
 up\nKAVITA LAMROR\,&nbsp\;Partner\, RWE &amp\; Digital Transformation\,&n
 bsp\;Maxis Clinical Sciences\nSWEETY MATHEW\,&nbsp\;Regulatory Profession
 al\, RA CMC Biotech &amp\; Rare Disease\,&nbsp\;Novo Nordisk\nNEELU GOEL\
 ,&nbsp\;Regulatory Affairs - Head Business continuity &amp\; Compliance\,
 &nbsp\;Sun Pharma\nAPARNA PRABHUNE\,&nbsp\;Asst General Manager Regulator
 y Affairs\,&nbsp\;Wockhardt\n\nPlus more joining soon\n\nKEY THEMES DISCU
 SSED:\n\n\nCurrent regulatory framework – contemporary developments at a 
 glance - Making the best out of the situation\nOutlining major legal chal
 lenges currently faced – Ways to cross these barriers\n‘One Quality One S
 tandard’ - Proposal for linking State &amp\; Central Drug Regulatory bodi
 es for their innovative processes\nRWE / RWD - How it could be used to su
 pport regulatory decision-making\nCurrent regulatory compliance issues &a
 mp\; opportunities for regulatory authorities &amp\; industry\nImpact of 
 technology - How do digital applications conflict with the legal &amp\; r
 egulatory landscape?\nRecent Clinical development - Recent regulatory upd
 ates – The new normal\nRemote trials – finally the reality – Regulations\
 nOvercoming the main challenges of filing variations in India\n"Engaging 
 Patients for Patient Safety"\, "Elevate the Voice of Patients"\nEvolving 
 Predicaments in Regulations of Medical Devices\nIndia\, An Emerging Pivot
  for Biosimilars - A detailed glimpse into current streamlines &amp\; gui
 dance\nDrug Licensing &amp\; advancing approaches – proposal of exclusive
  bills for drug dealing authority\nQuality audits to ensure compliance wi
 th regulatory requirements\nReplacement of the surviving act by The New D
 rugs\, Medical Devices and Cosmetics Bill\, 2023\nOvercoming key challeng
 es with product registration in India\nOutlining key requirements for fil
 ing variations in India\nPractical guidance for drug registration complia
 nce in India\nNavigating the best regulatory pathway for successful drug 
 approval\nBe part of a major networking opportunity\n\nWHO SHOULD ATTEND 
 AND WHO YOU’LL MEET:\n\nThis conference is specifically designed for phar
 ma\, biotech\, CRO’s\, Government and Regulators\, Hospitals/Trial Sites\
 , Technology &amp\; Solution Providers and medical device professionals r
 esponsible for:\n\nRegulatory Affairs\, Regulatory Writing/Medical Writin
 g/Publishing / Information/ Submissions\, Document and eRecords Managemen
 t\, Drug Safety\, Business Operations/Processing\, Labelling\, Clinical T
 rials Management/Data\, Clinical Data\, Outsourcing/Clinical Outsourcing/
 Vendor Management\, Product Development\, Quality Assurance/Quality Contr
 ol\,Patient recruitment companies\, Government- Department of health\, No
 n-profit organizations/ Association\, Consultants.\n\nGet more from the e
 vent\, with a broader scope bringing the whole communications value chain
  together. Enjoy and make the best out of our dedicated networking time\,
  meet the leading international vendors showcasing the products of tomorr
 ow in the co-located exhibition. Expand your knowledge of the latest busi
 ness models and strategies in the high-level conference.\n
DTEND:20240321T170000
DTSTAMP:20260512T232256Z
DTSTART:20240321T090000
LOCATION:Kohinoor Continental\, Andheri - Kurla Road\, Konkan Division\, 4
 00059\,
SEQUENCE:0
SUMMARY:7th Annual Pharma Regulatory 2024\n&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nb
 sp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\
 ;&nbsp\;&nbsp\;&nbsp\;&nbs...
UID:ef6dc713-0751-454c-bca7-faa3aee1b669
END:VEVENT
END:VCALENDAR